ESTEBAN MARTINEZ

Senior Consultant & Associate Professor of Medicine

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Alexy Inciarte

Associated profesor

University of Barcelona

SPAIN

View details

Josep Mallolas Masferrer

Professor of Medicina

University of Barcelona

SPAIN

View details

Jaime Vera

Professor in HIV Medicine

Brighton and Sussex Medical School

UNITED KINGDOM

View details

Roger Paredes

Chief

Hospital Universitari Germans Trias i Pujol

SPAIN

View details

Chloe Orkin

UNITED KINGDOM

View details

Mar Masiá

SPAIN

View details

Montserrat Laguno Centeno

Institut d'Investigacions Biomèdiques August Pi i Sunyer

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

ESTEBAN MARTINEZ

Research Interests

Explore related searches

Contact this professor

Articles (10)

Ageism: the -ism affecting the lives of older people living with HIV

Considerations on the Associations Between Antiretroviral Regimen and Changes in Blood Pressure in the D2EFT Study

Cardiometabolic health in people with HIV: expert consensus review

Efficacy and safety of raltegravir plus lamivudine maintenance therapy.

Lenacapavir plus two bNAbs: feasible, with some caveats.

Incidence of hypertension and blood pressure changes in persons with HIV at high risk for cardiovascular disease switching from boosted protease inhibitors to dolutegravir: a post-hoc analysis of the 96-week randomised NEAT-022 trial.

Clinical use and effectiveness of dolutegravir and lamivudine: a long-term, real-world, retrospective study

Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir

Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life setting.

Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023.

Collaborators (7)

Alexy Inciarte

Josep Mallolas Masferrer

Jaime Vera

Roger Paredes

Chloe Orkin

Mar Masiá

Montserrat Laguno Centeno

Make your next move.